Effects of a Health Workforce Capacity Building & Quality Improvement

Status Completed

Clinical Trial Summary

The aim of the study is to evaluate a health workforce capacity building and quality improvement intervention focused on integrated day-of-birth and post-pregnancy care at 16 hospitals in Kinshasa, Democratic Republic of Congo. The intervention package consists of a low-dose, high-frequency (LDHF) training of health workers, support for quality improvement teams, and provision of critical equipment, supplies and drugs within a quality improvement (QI) framework.

Clinical Trial Description

The health workforce capacity building and quality improvement intervention will be implemented in two phases: eight facilities will receive the intervention in phase 1 and the remaining eight facilities will receive the intervention in phase 2.

Objective 1: For objective 2 on facility-based health outcomes, the study design is a cluster-randomized evaluation in phase 1. The intervention's effects will be assessed by comparing an intervention group and a control group of facilities. These will be selected from 16 Kinshasa health facilities. Intervention and control facilities' monthly reported health outcomes will be compared in a 12-month baseline period and 12-month period during and after the intervention implementation (Phase 1) in a difference-in-difference analysis. In Phase 2, all facilities will have their monthly service statistics and health outcomes reviewed for trends in improvement.

Overall, in Phase 1, eight intervention sites will be matched to eight sites serving as controls. In Phase 2, the eight Phase 1 control sites will then receive the same package as the intervention sites in Phase 1. Sites will be stratified by case load, low and high (over 90 births per month), and funding (public or private funding). Within each stratum, prior to start of the intervention, there will be random selection to intervention and control groups to allow for baseline comparability between groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03363308
Study type	Interventional
Source	Jhpiego
Contact
Status	Completed
Phase	N/A
Start date	November 16, 2017
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03605511` - TTP and aHUS in Complicated Pregnancies
Completed	`NCT02379728` - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth	N/A
Not yet recruiting	`NCT01664546` - Study of the Best Blastocyst Post Transfer by aCGH	N/A
Completed	`NCT02218931` - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes	N/A
Recruiting	`NCT03662178` - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Completed	`NCT03290924` - Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach	N/A
Recruiting	`NCT05901688` - Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Recruiting	`NCT02339077` - Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting	N/A
Completed	`NCT03112018` - Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda	N/A
Completed	`NCT02862925` - Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.	N/A
Completed	`NCT02318420` - The PartoMa Project: For Improving Monitoring, Action and Triage During Labour	N/A
Recruiting	`NCT05757167` - Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics	Phase 4
Completed	`NCT02148952` - BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program	N/A
Active, not recruiting	`NCT01995968` - Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.	N/A
Completed	`NCT00270530` - Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia	Phase 4
Completed	`NCT04600076` - MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers	N/A
Completed	`NCT03722615` - Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
Completed	`NCT02907242` - Revealed Versus Concealed Cerebroplacental Ratio	N/A
Recruiting	`NCT02336243` - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders	Phase 3
Completed	`NCT00133744` - Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms